Elizence Lifecare Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.45 Cr
as on 13-12-2024
- Company Age 48 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 18.94%
(FY 2019)
- Profit 387.77%
(FY 2019)
- Ebitda -35.29%
(FY 2019)
- Net Worth 0.03%
(FY 2019)
- Total Assets -0.02%
(FY 2019)
About Elizence Lifecare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 1.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satinder Jain, Vibhor Jain, and Nagina Jain serve as directors at the Company.
- CIN/LLPIN
U85110DL1976PLC008434
- Company No.
008434
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Dec 1976
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Elizence Lifecare Limited offer?
Elizence Lifecare Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Digestive System Drugs & Medicines, Antacid Drugs, Vitamin Tablets & Capsules, Cleaning Liquids & Wipes.
Who are the key members and board of directors at Elizence Lifecare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satinder Jain  | Director | 14-Dec-1976 | Current |
| Vibhor Jain | Director | 22-Mar-2003 | Current |
| Nagina Jain | Director | 15-Sep-2018 | Current |
Financial Performance of Elizence Lifecare.
Elizence Lifecare Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 18.94% increase. The company also saw a substantial improvement in profitability, with a 387.77% increase in profit. The company's net worth moved up by a moderate rise of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elizence Lifecare?
In 2017, Elizence Lifecare had a promoter holding of 83.58% and a public holding of 16.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kylsans Drugs And Chemicals Private Ltd.Active 35 years 10 monthsSatinder Jain and Vibhor Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elizence Lifecare?
Unlock and access historical data on people associated with Elizence Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elizence Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elizence Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
